Skip to content

Application of S-Ketamine in single-port thoracoscopic surgery under spontaneous breathing laryngeal mask anesthesia

Application of S-Ketamine in single-port thoracoscopic surgery under spontaneous breathing laryngeal mask anesthesia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053990
Enrollment
Unknown
Registered
2021-12-06
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic disease

Interventions

Experimental group1:The induction dose of S-ketamine was 1mg/kg+ the maintenance dose was 0.15mg/kg/h
Experimental group2:The induction dose of S-ketamine was 1mg/kg+ the maintenance dose was 0.3mg/kg/h
Experimental group3:The induction dose of S-ketamine was 1mg/kg+ the maintenance dose was 0.45mg/kg/h
Control group:Routine anesthesia induction + remifentanil maintenance

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, no gender restrictions; 2. The single-port thoracoscopic pulmonary surgery is to be performed, and the operation process is simple, and the required time is less than 2 hours; 3. Less airway secretions and no extensive adhesions; 4. American Society of Anesthesiologists ASA I~III grade; 5. Informed consent, voluntarily participate in the trial, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. History of surgery in the pharynx, abnormal tracheal anatomy or lesions involving the bronchi; 2. Patients who are judged to be difficult to manage the respiratory tract (modified Markov score is grade IV); 3. There are infectious lesions in the lungs, and there are more secretions in the airway, or there are symptoms of hemoptysis; 4. Pulmonary function suggests the existence of ventilation and (or) ventilation dysfunction; 5. Anemia or thrombocytopenia, Hb= 2.5 x ULN, TBIL >= 1.5 x ULN; 7. Abnormal renal function, serum creatinine is greater than the upper limit of normal; 8. Those who are allergic to or have contraindications to esketamine, benzodiazepines, opioids, propofol, lidocaine and their drug components; 9. Previous history of mental illness such as depression, schizophrenia, bipolar affective disorder; 10. Obese (body mass index > 30 kg/m2); 11. Subjects deemed unfit for participation in this study by the investigator.

Design outcomes

Primary

MeasureTime frame
Anesthesia success rate;

Secondary

MeasureTime frame
Waking hours;Time of operation;The proportion of double lumen tubes transferred in the first three groups;The amount of time respiratory depression caused surgery to pause;Incidence of intraoperative cough;Incidence of hypoxemia;Basic vital signs;Postoperative adverse reaction;

Countries

China

Contacts

Public ContactJi Zhonghua

Shanghai East Hospital

jzh20091125@163.com+86 13823083858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026